Why renaming my health condition could help other women

**Health**

## Renaming PCOS: A Global Movement for Understanding and Improved Care for Millions of Women

**[City, State] –** Rochelle Lewis is at the forefront of a growing global initiative calling for the renaming of Polycystic Ovary Syndrome (PCOS), a complex and often misunderstood condition affecting over 170 million women worldwide. Lewis, among the millions diagnosed with PCOS, argues that the current name is a significant barrier to accurate understanding, timely diagnosis, and comprehensive treatment.

Despite its name, not all women with PCOS develop ovarian cysts; many instead have multiple follicles that appear polycystic on ultrasound. Crucially, the “ovary” in its name misrepresents PCOS as solely a reproductive issue, when it is, in fact, a complex, multi-system endocrine and metabolic disorder. Symptoms range from irregular menstrual cycles, infertility, and hirsutism (excess hair growth) to insulin resistance, increased risk of type 2 diabetes, cardiovascular disease, and mental health challenges like anxiety and depression. The term “syndrome” can also diminish the perceived severity and systemic nature of the condition, leading to underdiagnosis and fragmented care.

Lewis emphasizes that this misleading nomenclature contributes to a critical lack of awareness among both the public and medical professionals, often delaying diagnosis by years and focusing treatment primarily on reproductive symptoms, while neglecting the broader health implications.

A new, more accurate name could drastically improve patient education, enhance early detection, and encourage a holistic approach to treatment that addresses all aspects of the condition. Medical experts and patient advocacy groups increasingly echo this sentiment, acknowledging that the current terminology creates confusion and impacts patient pathways. Global consensus is growing that a nomenclature change could de-stigmatize the condition and encourage more inclusive research and funding.

With over 170 million women globally affected, and many more likely undiagnosed, the call for clarity is urgent. The movement, championed by individuals like Rochelle Lewis, represents a pivotal moment in recognizing the full scope of PCOS and striving for a future where its name accurately reflects its complexity, leading to better outcomes for millions of women worldwide.